Company · CIK 2020932

# AgomAb Therapeutics NV

| CIK | [2020932](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002020932) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | C9 |
| Listed | AGMB (Nasdaq) |
| First annual or quarterly report | 2026-04-23 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-292790 | IPO Final prospectus | 2026-01-16 | 2026-02-06 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-02-06 | [424B4](https://www.sec.gov/Archives/edgar/data/2020932/000110465926011523/0001104659-26-011523-index.htm) Final prospectus | 333-292790 | 0001104659-26-011523 |
| 2026-01-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2020932/999999999526000416/9999999995-26-000416-index.htm) Declared effective | 333-292790 | 9999999995-26-000416 |
| 2026-01-29 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2020932/000110465926007712/0001104659-26-007712-index.htm) Amendment | 333-292790 | 0001104659-26-007712 |
| 2026-01-16 | [F-1](https://www.sec.gov/Archives/edgar/data/2020932/000110465926004558/0001104659-26-004558-index.htm) Registration filed | 333-292790 | 0001104659-26-004558 |
| 2024-06-20 | [DRS](https://www.sec.gov/Archives/edgar/data/2020932/000110465924073452/0001104659-24-073452-index.htm) Draft made public | 377-07291 | 0001104659-24-073452 |

[All filings of this company](https://equitycapital.markets/filings?cik=2020932) · [CSV](https://equitycapital.markets/filings.csv?cik=2020932)

---
Source page: https://equitycapital.markets/company/2020932 · Data: U.S. SEC EDGAR · CC BY 4.0